Related Experiment Video
Updated: Mar 12, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Impact of a maternal immunization program against pertussis in a developing country
Carla Vizzotti1, Maria V Juarez1, Eduardo Bergel2
1Dirección Nacional de Control de Enfermedades Inmunoprevenibles (DiNaCEI), Ministerio de Salud de la Nación, Argentina.
Maternal immunization with the Tdap vaccine significantly reduced pertussis (whooping cough) in infants in Argentina. This strategy protects young babies too early for vaccination.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Pertussis (whooping cough) poses a significant threat in developing nations, with Argentina experiencing a surge in cases and deaths in 2011.
- Over half of pertussis-related infant fatalities in Argentina occurred in infants under two months old, a demographic too young for primary immunization.
Purpose of the Study:
- To evaluate the impact of a maternal Tdap immunization program on reducing infant pertussis morbidity and mortality in Argentina.
- To assess the effectiveness of vaccinating pregnant women against pertussis in protecting young infants.
Main Methods:
- A Bayesian structural time-series model was employed to compare Argentinean states with high (>50%) and low (<=50%) Tdap vaccine coverage.
- States with low vaccine coverage served as a control group, with time series data analyzed before and after the Tdap program implementation.
Main Results:
- A 51% relative reduction in pertussis cases was observed in high-coverage states compared to low-coverage areas.
- Infants aged two to six months experienced a 44% reduction in pertussis illness.
- Pertussis-related deaths decreased by 87% from 2011 to 2013 in the high-coverage regions.
Conclusions:
- Maternal Tdap immunization demonstrates an age-dependent protective effect for infants under six months in a developing country.
- The findings support the implementation of maternal immunization programs as a key strategy to control pertussis in vulnerable infant populations.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Microorganisms in Medicine and Therapeutics
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...